The gammaherpesvirus m2 protein manipulates the Fyn/Vav pathway through a multidocking mechanism of assembly

PLoS ONE

Volumn 3, Issue 2, 2008, Pages

  de Miranda, Marta Pires ^a,b   Alenquer, Marta ^a,b   Marques, Sofia ^a,b   Rodrigues, Lénia ^a,b   Lopes, Filipa ^a,b   Bustelo, Xosé R ^c   Simas, J Pedro ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTYROSINE; PROLINE; PROTEIN KINASE FYN; PROTEIN M2; PROTEIN SH2; TYROSINE; VAV PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC TRANSFECTION; HERPES VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; LATENT PERIOD; MOUSE; NONHUMAN; PLASMID; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; VIRUS INFECTION; VIRUS MUTATION;

ANIMALS; FEMALE; GAMMAHERPESVIRINAE; MICE; MICE, INBRED BALB C; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FYN; PROTO-ONCOGENE PROTEINS C-VAV; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRUS LATENCY;

MURINAE; MUS;

EID: 45749086951     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001654     Document Type: Article

References (49)

1. Rickinson AB, Kieff E (2007) Epstein-Barr Virus. In: Knipe DM, Howley P, eds. Fields Virology. Philadelphia: Lippincott-Raven. pp 2655-2670.
2. Damania B (2004) Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis. Nat Rev Microbiol 2: 656-668.
3. Thorley-Lawson DA (2001) Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 1: 75-82.
4. Jumaa H, Hendriks RW, Reth M (2005) B cell signaling and tumorigenesis. Annu Rev Immunol 23: 415-445.
5. Fruehling S, Longnecker R (1997) The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235: 241-251.
6. Caldwell RG, Wilson JB, Anderson SJ, Longnecker R (1998) Epstrin-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9: 405-411.
7. Merchant M, Swart R, Katzman RB, Ikeda M, Ikeda A, et al. (2001) The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function. Int Rev Immunol 20: 805-835.
8. Lagunoff M, Majeti R, Weiss A, Ganem D (1999) Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc Nail Acad Sci U S A 96: 5704-5709.
9. Lee BS, Lee SH, Feng P, Chang H, Cho NH, et al. (2005) Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome. J Virol 79: 12173-12184.
10. Lee H, Goo J, Li M, Choi JK, DeMaria M, et al. (1998) Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvicus. Mol Cell Biol 18: 5219-5228.
11. Tomlinson CC, Damania B (2004) The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J Virol 78: 1918-1927.
12. Brinkmann MM, Schulz TF (2006) Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae. J Gen Vicol 87: 1047-1074.
13. Simas JP, Efstathiou S (1998) Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol 6: 276-282.
14. Stevenson PG, Efstathiou S (2005) Immune mechanisms in murine gammaherpesvirus-68 infection. Viral Immuriol 18: 445-456.
15. Flano E, Kim IJ, Moore J, Woodland DL, Blackman MA (2003) Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J Immunol 170: 3828-3834.
16. Flano E, Kim IJ, Woodland DL, Blackman MA (2002) Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med 196: 1363-1372.
17. Simas JP, Marques S, Bridgeman A, Efstathiou S, Adler H (2004) The M2 gene product of morine gammaherpesvirus 68 is required for efficient colonization of splenic follicles but is not necessary for expansion of latently infected germinal centre B cells. J Gen Virol 85: 2789-2797.
18. Simas JP, Swann D, Bowden R, Efstathiou S (1999) Analysis of murine gammaherpesvirus-68 transcription during lytic and latent infection. J Gen Virol 80 (Pt 1): 75-82.
19. Willer DO, Speck SH (2003) Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J Virol 77: 8310-8321.
20. Marques S, Efstathiou S, Smith KG, Haury M, Simas JP (2003) Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J Virol 77: 7308-7318.
21. Virgin HWt, Latreille P, Wamsley P, Hallsworth K, Weck KE, et al. (1997) Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71; 5894-5904.
22. Rodrigues L, Pires de Miranda M, Caloca MJ, Bustelo XR, Simas JP (2006) Activation of Vav by the gammaherpesvirus M2 protein contributes to the establishment of viral latency in B lymphocytes. J Virol 80: 6123-6135.
23. Bustelo XR (2001) Vav proteins, adaptors and cell signaling. Oncogene 20: 6372-6381.
24. Bustelo XR, Sauzeau V, Berenjeno IM (2007) GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 29: 356-370.
25. Husain SM, Usherwood EJ, Dyson H, Coleclough C, Coppola MA, et al. (1999) Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes. Proc Natl Acad Sci U S A 96: 7508-7513.
26. Kim KJ, Kanellopoulos-Langevin C, Merwin RM, Sachs DH, Asofsky R (1979) Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol 122: 549-554.
27. Aghazadeh B, Lowry WE, Huang XY, Rosen MK (2000) Structural basis for relief of autoinhibition of the Db1 homology domain of proto-oncogene Vav by tyrosine phosphorylation. Cell 102: 625-633.
28. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR (1997) Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385: 169-172.
29. Llorca O, Arias-Palomo E, Zugaza JL, Bustelo XR (2005) Global conformational rearrangements during the activation of the GDP/GTP exchange factor Vav3. Embo J 24: 1330-1340.
30. Herskowitz J, Jacoby MA, Speck SH (2005) The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B ceus. J Virol 79: 2261-2273.
31. Jacoby MA, Virgin HWt, Speck SH (2002) Disruption of the M2 gene of murine gammaherpiesvirus 68 alters splenic latency following intranwal, but not intraperitoneal, inoculation. J Virol 76: 1790-1801.
32. Macrae AI, Usherwood EJ, Husain SM, Flano E, Kim IJ, et al. (2003) Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis. J Virol 77: 9700-9709.
33. Sunil-Chandra NP, Efstathiou S, Arno J, Nash AA (1992) Virological and pathological features of mice infected with murine gamma-berpesvirus 68. J Gen Virol 73 (Pt 9): 2347-2356.
34. Bowden RJ, Simas JP, Davis AJ, Efstathiou S (1997) Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency. J Gen Virol 78 (Pt 7): 1675-1687.
35. Liang X, Shin YC, Means RE, Jung JU (2004) Inhibition of interferon-mediated antiviral activity by murine gammaherpesvirus 68 latency-associated M2 protein. J Virol 78: 12416-12427.
36. Liarig X, Pickering MT, Cho NH, Chang H, Volkert MR, et al. (2006) Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2. J Virol 80: 5862-5874.
37. Bustelo XR (2000) Regulatory and signaling properties of the Vav family. Mol Cell Biol 20: 1461-1477.
38. Meng W, Numazaki M, Takeuchi K, Uchibori Y, Ando-Akatsuka Y, et al. (2004) DIP (mDia interacting protein) is a key molecule regulating Rho and Rae in a Src-dependent manner. Ernbo J 23: 760-771.
39. Crespo P, Bustelo XR, Aaronson DS, Coso OA, Lopez-Barahona M, et al. (1996) Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. Oncogene 13: 455-460.
40. Billadeau DD, Mackie SM, Schoon RA, Leibson PJ (2000) The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity. J Exp Med 192: 381-392.
41. Andoniou CE, Lill NL, Thien CB, Lupher ML Jr, Ota S, et al. (2000) The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation. Mol Cell Biol 20: 851-867.
42. Tezuka T, Umemori H, Akiyama T, Nakanishi S, Yamamoto T (1999) PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc Natl Acad Sci U S A 96: 435-440.
43. Yang W, Malek SN, Desiderio S (t995) An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo. J Biol Chem 270: 20832-20840.
44. Zugaza JL, Lopez-Lago MA, Caloca MJ, Dosil M, Movilia N, et al. (2002) Structural determinants for the biological activity of Vav proteins. J Biol Chem 277: 45377-45392.
45. Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, et al. (1994) Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol 14: 2777-2785.
46. Lopez-LagG M, Lee H, Cruz C, Movilla N, Bustelo XR (2000) Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav. Mol Cell Biol 20: 1678-1691.
47. Adler H, Messerle M, Wagner M, Koszinowski UH (2000) Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol 74: 6964-6974.
48. Adler H, Messerle M, Koszinowski UH (2001) Virus reconstituted from infectious bacterial artificial chromosome (BAC)-cloned murine gammaherpesvirus 68 acquires wild-type properties in vivo only after excision of BAC vector sequences. J Virol 75: 5692-5696.
49. Simas JP, Bowden RJ, Paige V, Efstathiou S (1998) Four tRNA-like sequences and a serpin homologue encoded by murine gammaherpesvirus 68 are dispensable for lytic replication in vitro and latency in vivo. J Gen Virol 79 (Pt 1): 149-153.